Sign in
CompletedNo phase

Association Between Hypomagnesemia and Coagulopathy in Sepsis

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
150 people enrolled
Started
1 Apr 2025
Ended
1 Apr 2025
Type of study
Observational, 3 groups
Treatments tested
  • Serum magnesium concentration
Record updated
8 May 2026

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ≥ 20 years at the time of Intensive Care Unit (ICU) admission
  • Diagnosis of sepsis based on Sepsis-3 criteria [confirmed or suspected infection + Sequential Organ Failure Assessment (SOFA) score ≥ 2]
  • Admission to the ICU during the study period
  • Serum magnesium level measured at ICU admission
  • Coagulation parameters [e.g., platelet count, Prothrombin Time/International Normalized Ratio (PT-INR), fibrinogen, D-dimer] within 24 hours of ICU admission
  • Complete clinical and laboratory data for calculating the International Society on Thrombosis and Haemostasis (ISTH) overt Disseminated Intravascular Coagulation (DIC) score

Who cannot take part

  • ICU admissions due to non-infectious causes (e.g., trauma, elective surgery without infection)
  • Presence of pre-existing coagulopathy or hematologic malignancy affecting baseline coagulation (e.g., leukemia, hemophilia)
  • Patients with missing data on serum magnesium or coagulation markers at ICU admission
  • Known history of magnesium supplementation prior to ICU admission
  • End-stage renal disease on dialysis, which may significantly alter magnesium handling
  • Pregnant women, due to altered magnesium physiology
  • Patients transferred from or to another hospital within 24 hours of ICU admission (incomplete follow-up)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aimed to investigate the association between hypomagnesemia and coagulopathy in patients with sepsis, with a focus on evaluating whether low serum magnesium levels are independently linked to the development of disseminated intravascular coagulation during intensive care unit admission.

The 3 groups in the trial

  • Group I

    Patients with hypomagnesemia.

    Treatment: Serum magnesium concentration

  • Group II

    Individuals with normal serum magnesium levels

    Treatment: Serum magnesium concentration

  • Group III

    Patients with hypermagnesemia.

    Treatment: Serum magnesium concentration

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Association Between Hypomagnesemia and Coagulopathy in Sepsis
Record updated
8 May 2026